全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

A Rare Case of Autosomal Recessive Alport Syndrome Due to Mutation in COL 4A4 Gene with 1 Base Pair Duplication of Cytosine Nucleotide
—A Rare Mutation in Alport Syndrome

DOI: 10.4236/ojneph.2025.152024, PP. 247-251

Keywords: Alport Syndrome, Angiotensin Converting Enzyme Inhibitors, Genetic Testing, Microscopic Hematuria

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background: Alport syndrome (AS) is a rare genetic disorder due to mutations in type IV collagen genes. The case: A 16-year-old boy was referred for management of moderate renal disease and hypertension that was disclosed after routine testing for sensorineural deafness. Laboratory tests showed serum creatinine at 200 umol/L, microscopic hematuria and proteinuria at 2.6 g/day. Diagnosis of Alport syndrome (AS) was established by kidney biopsy and genetic testing that disclosed a rare AS-mutation. The biopsy showed focal and segmental glomerulosclerosis, without deposits on immunofluorescent stains, and abnormal glomerular basement membrane with a basket-weave appearance on electron microscopy. Genetic testing showed homozygous frameshift insertion in COL4A4 gene that consisted of 1 base pair duplication of cytosine nucleotide resulting in splice-site changes. Genetic testing of both parents did not show abnormality, indicating a new mutation in this patient. He was treated with Ramipril 5 mg daily and diet low in salt and protein. By 1 year later; he remained stable with serum creatinine at 219 umol/L, albumin at 39 g/L and protein excretion at 450 mg/day. Conclusion: AS can evolve due to new cytosine mutations in aggressive renal disease that can be ameliorated with angiotensin-converting enzyme inhibitors.

References

[1]  Sohar, E. (1954) A Heredo-Familial Syndrome Characterized by Renal Disease, Inner Ear Deafness, and Ocular Changes. Harefuah, 47, 161-162.
[2]  Kashtan, C.E., Ding, J., Garosi, G., Heidet, L., Massella, L., Nakanishi, K., et al. (2018) Alport Syndrome: A Unified Classification of Genetic Disorders of Collagen IV Α345: A Position Paper of the Alport Syndrome Classification Working Group. Kidney International, 93, 1045-1051.
https://doi.org/10.1016/j.kint.2017.12.018
[3]  Alport, A.C. (1927) Hereditary Familial Congenital Haemorrhagic Nephritis. British Medical Journal, 1, 504-506.
https://doi.org/10.1136/bmj.1.3454.504
[4]  Levy, M. and Feingold, J. (2000) Estimating Prevalence in Single-Gene Kidney Diseases Progressing to Renal Failure. Kidney International, 58, 925-943.
https://doi.org/10.1046/j.1523-1755.2000.00250.x
[5]  Savige, J., Ariani, F., Mari, F., Bruttini, M., Renieri, A., Gross, O., et al. (2018) Expert Consensus Guidelines for the Genetic Diagnosis of Alport Syndrome. Pediatric Nephrology, 34, 1175-1189.
https://doi.org/10.1007/s00467-018-3985-4
[6]  Savige, J., Huang, M., Croos Dabrera, M.S., Shukla, K. and Gibson, J. (2022) Genotype-Phenotype Correlations for Pathogenic COL4A3–COL4A5 Variants in X-Linked, Autosomal Recessive, and Autosomal Dominant Alport Syndrome. Frontiers in Medicine, 9, Article 865034.
https://doi.org/10.3389/fmed.2022.865034
[7]  Montenegro, L.R., Lerário, A.M., Nishi, M.Y., Jorge, A.A.L. and Mendonca, B.B. (2021) Performance of Mutation Pathogenicity Prediction Tools on Missense Variants Associated with 46, XY Differences of Sex Development. Clinics, 76, e2052.
https://doi.org/10.6061/clinics/2021/e2052
[8]  Zhang, Y. and Ding, J. (2017) Renal, Auricular, and Ocular Outcomes of Alport Syndrome and Their Current Management. Pediatric Nephrology, 33, 1309-1316.
https://doi.org/10.1007/s00467-017-3784-3
[9]  Gudmundsson, S., Singer-Berk, M., Watts, N.A., Phu, W., Goodrich, J.K., Solomonson, M., et al. (2021) Variant Interpretation Using Population Databases: Lessons from gnomAD. Human Mutation, 43, 1012-1030.
https://doi.org/10.1002/humu.24309
[10]  Mabillard, H., Ryan, R., Tzoumas, N., Gear, S. and Sayer, J.A. (2024) Explaining Alport Syndrome—Lessons from the Adult Nephrology Clinic. Journal of Rare Diseases, 3, Article No. 14.
https://doi.org/10.1007/s44162-024-00036-z
[11]  Kashtan, C.E. and Gross, O. (2020) Clinical Practice Recommendations for the Diagnosis and Management of Alport Syndrome in Children, Adolescents, and Young Adults—An Update for 2020. Pediatric Nephrology, 36, 711-719.
https://doi.org/10.1007/s00467-020-04819-6
[12]  Tryggvason, K., Heikkilä, P., Pettersson, E., Tibell, A. and Thorner, P. (1997) Can Alport Syndrome Be Treated by Gene Therapy? Kidney International, 51, 1493-1499.
https://doi.org/10.1038/ki.1997.205

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133